Cargando…
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence infor...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148658/ https://www.ncbi.nlm.nih.gov/pubmed/37099021 http://dx.doi.org/10.1167/iovs.64.4.31 |
_version_ | 1785035020529827840 |
---|---|
author | Bai, Xue Ye, Dan Shi, Yuxun Fan, Matthew Lu, Peng Feng, Yanlin Hu, Chenyang Liao, Jing Cui, Kaixuan Tang, Xiaoyu Wu, Peiqi Xu, Fan Xu, Yue Huang, Jingjing |
author_facet | Bai, Xue Ye, Dan Shi, Yuxun Fan, Matthew Lu, Peng Feng, Yanlin Hu, Chenyang Liao, Jing Cui, Kaixuan Tang, Xiaoyu Wu, Peiqi Xu, Fan Xu, Yue Huang, Jingjing |
author_sort | Bai, Xue |
collection | PubMed |
description | PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence information regulator 1 (Sirt1). Here, we investigated whether SRT2104 could protect the retina from ischemia/reperfusion (I/R) injury and the underlying mechanisms. METHODS: SRT2104 was intravitreally injected immediately after I/R induction. RNA and protein expression were detected by quantitative real-time PCR and Western blot. Protein expression and distribution were examined by immunofluorescence staining. Retinal structure and function were analyzed by hematoxylin and eosin staining, optical coherence tomography, and electroretinogram. Optic nerve axons were quantified using toluidine blue staining. Cellular apoptosis and senescence were evaluated by TUNEL assay and SA-β-gal staining. RESULTS: The protein expression of Sirt1 decreased dramatically after I/R injury and SRT2104 administration effectively enhanced the stability of Sirt1 protein without significantly influencing Sirt1 mRNA synthesis. SRT2104 administration alone exerted no influence on the structure and function of normal retinas. However, SRT2104 intervention significantly protected the inner retinal structure and neurons; partially restored retinal function after I/R injury. I/R-induced cellular apoptosis and senescence were effectively alleviated by SRT2104 administration. Additionally, SRT2104 intervention markedly reduced neuroinflammation, including reactive gliosis, retinal vascular inflammation, and the overexpression of pro-inflammatory cytokines after I/R injury. Mechanistically, I/R-induced acetylation of p53, NF-κB p65, and STAT3 was significantly reversed by SRT2104 intervention. CONCLUSIONS: We demonstrated that SRT2104 exerted potent protective effects against I/R injury by enhancing Sirt1-mediated deacetylation and suppressing apoptosis, senescence, and neuroinflammation-related pathways. |
format | Online Article Text |
id | pubmed-10148658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-101486582023-04-30 Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation Bai, Xue Ye, Dan Shi, Yuxun Fan, Matthew Lu, Peng Feng, Yanlin Hu, Chenyang Liao, Jing Cui, Kaixuan Tang, Xiaoyu Wu, Peiqi Xu, Fan Xu, Yue Huang, Jingjing Invest Ophthalmol Vis Sci Glaucoma PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence information regulator 1 (Sirt1). Here, we investigated whether SRT2104 could protect the retina from ischemia/reperfusion (I/R) injury and the underlying mechanisms. METHODS: SRT2104 was intravitreally injected immediately after I/R induction. RNA and protein expression were detected by quantitative real-time PCR and Western blot. Protein expression and distribution were examined by immunofluorescence staining. Retinal structure and function were analyzed by hematoxylin and eosin staining, optical coherence tomography, and electroretinogram. Optic nerve axons were quantified using toluidine blue staining. Cellular apoptosis and senescence were evaluated by TUNEL assay and SA-β-gal staining. RESULTS: The protein expression of Sirt1 decreased dramatically after I/R injury and SRT2104 administration effectively enhanced the stability of Sirt1 protein without significantly influencing Sirt1 mRNA synthesis. SRT2104 administration alone exerted no influence on the structure and function of normal retinas. However, SRT2104 intervention significantly protected the inner retinal structure and neurons; partially restored retinal function after I/R injury. I/R-induced cellular apoptosis and senescence were effectively alleviated by SRT2104 administration. Additionally, SRT2104 intervention markedly reduced neuroinflammation, including reactive gliosis, retinal vascular inflammation, and the overexpression of pro-inflammatory cytokines after I/R injury. Mechanistically, I/R-induced acetylation of p53, NF-κB p65, and STAT3 was significantly reversed by SRT2104 intervention. CONCLUSIONS: We demonstrated that SRT2104 exerted potent protective effects against I/R injury by enhancing Sirt1-mediated deacetylation and suppressing apoptosis, senescence, and neuroinflammation-related pathways. The Association for Research in Vision and Ophthalmology 2023-04-26 /pmc/articles/PMC10148658/ /pubmed/37099021 http://dx.doi.org/10.1167/iovs.64.4.31 Text en Copyright 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Glaucoma Bai, Xue Ye, Dan Shi, Yuxun Fan, Matthew Lu, Peng Feng, Yanlin Hu, Chenyang Liao, Jing Cui, Kaixuan Tang, Xiaoyu Wu, Peiqi Xu, Fan Xu, Yue Huang, Jingjing Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation |
title | Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation |
title_full | Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation |
title_fullStr | Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation |
title_full_unstemmed | Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation |
title_short | Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation |
title_sort | neuroprotection of srt2104 in murine ischemia/reperfusion injury through the enhancement of sirt1-mediated deacetylation |
topic | Glaucoma |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148658/ https://www.ncbi.nlm.nih.gov/pubmed/37099021 http://dx.doi.org/10.1167/iovs.64.4.31 |
work_keys_str_mv | AT baixue neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT yedan neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT shiyuxun neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT fanmatthew neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT lupeng neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT fengyanlin neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT huchenyang neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT liaojing neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT cuikaixuan neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT tangxiaoyu neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT wupeiqi neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT xufan neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT xuyue neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation AT huangjingjing neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation |